Montevideo
Uruguay
21
2026-03-05
9
2026-04-07
These are the the leading inventors for applications assigned to Institut Pasteur de Montevideo:
Institut Pasteur de Montevideo based in Montevideo, UY has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS
#2 | 2025-11-20Methods Of Treatment Of Inflammation Related Conditions Using Pluripotent Anti-inflammatory And Metabolic Modulators
#3 | 2025-03-27Methods of Treatment of Inflammation Related Conditions Using Pluripotent Anti-Inflammatory and Metabolic Modulators
#4 | 2025-03-13VERSATILE IMMUNOGENIC MODULES AND NANOPARTICLES FOR TICK VACCINES
#5 | 2024-11-28ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS
#6 | 2024-05-09 â Patent 12,594,257 granted on 2026-04-07MEANS AND METHODS FOR IMPROVING ANTI-TUMORAL EFFICACY OF TRANSMEMBRANE CHANNEL PROTEIN BLOCKERS
#7 | 2023-11-02Methods of Treatment of Inflammation Related Conditions Using Pluripotent Anti-Inflammatory and Metabolic Modulators
#8 | 2022-09-22 â Patent 12,280,029 granted on 2025-04-22Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
#9 | 2022-06-16 â Patent 12,263,143 granted on 2025-04-01Ionic channel modulation as a method for treating tumors through inflammasome activation
#10 | 2021-07-15Methods of Treatment of Inflammation Related Conditions Using Pluripotent Anti-Inflammatory and Metabolic Modulators
#11 | 2021-04-29ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS
#12 | 2021-04-15NITROALKENE NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NA-NSAIDS) AND METHODS OF TREATING INFLAMMATION RELATED CONDITIONS
#13 | 2020-05-21Methods of Treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic Modulators
#14 | 2020-05-14 â Patent 11,400,066 granted on 2022-08-02Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
#15 | 2019-11-28 â Patent 10,906,864 granted on 2021-02-02Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDS) and methods of treating inflammation related conditions
#16 | 2019-06-27 â Patent 10,428,008 granted on 2019-10-01Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDs) and methods of treating inflammation related conditions
#17 | 2018-11-08 â Patent 11,246,858 granted on 2022-02-15Immunoresponsive methods of treating tumors
#18 | 2018-10-18Nitroalkene Trolox Derivatives and Methods of Use Thereof In The Treatment And Prevention of Inflammation Related Conditions
#19 | 2018-05-17SYSTEM, METHOD AND DEVICE FOR IDENTIFYING DISCRIMINANT BIOLOGICAL FACTORS AND FOR CLASSIFYING PROTEOMIC PROFILES
#20 | 2018-04-19 â Patent 10,537,537 granted on 2020-01-21Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
#21 | 2018-03-01 â Patent 9,994,541 granted on 2018-06-12Nitroalkene trolox derivatives and methods of use thereof in the treatment and prevention of inflammation related conditions
Also check out Institut Pasteur de Montevideo's (Montevideo, Uruguay) applicant profile with 18 patent applications submitted.
132669 â